Revvity reported $7.25B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Align Technology USD 4.15B 100.27M Mar/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Bio-Rad Laboratories USD 6.85B 602.3M Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Celltrion KRW 435.96B 16.26T Dec/2025
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Danaher USD 52.95B 415M Mar/2026
Dentsply International USD 1.32B 21M Mar/2026
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Illumina USD 2.68B 47M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Laboratory Of America USD 8.73B 108.8M Mar/2026
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 54.77M 335K Dec/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Mettler Toledo International USD -41.88M 18.25M Mar/2026
Myriad Genetics USD 337.4M 30.6M Mar/2026
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Organigram Holdings CAD 369.46M 20.33M Dec/2025
Ovoca Bio EUR 1.26M 7.41M Jun/2025
Pacific Biosciences Of California USD 2.37M 2.98M Mar/2026
Pharma Mar EUR 249.67M 2.16M Mar/2026
Qiagen NV USD 3.78B 128.73M Dec/2025
Quest Diagnostics USD 7.37B 196M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Repligen USD 2.11B 666K Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Sartorius EUR 2.73B 1.14B Mar/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
Waters USD 2.56B 230.55M Dec/2025
Zealand Pharma A/S 14.83B 331.99M Dec/2025
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026